Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Zhitao Ying, MD PhD, Wen Wang, MD, Xiaopei Wang, MD, Wen Zheng, MD, Ningjing Lin, MD PhD, Meifeng Tu, MD PhD, Yan Xie, MD PhD, Lingyan Ping, MD PhD, Chen Zhang, MD PhD, Weiping Liu, MD PhD, Lijuan Deng, MD PhD, Ming Hao, Su Yang, Yan Zhou, BSc, James Li, Yuqin Song, MD PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 5388.

https://doi.org/10.1182/blood-2018-99-114527

Published: 2018

Journal Articles

Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas

Jun Zhu, MD PhD, Junning Cao, MD, Lugui Qiu, MD PhD, Junyuan Qi, MD, Yuqin Song, MD PhD, Meifeng Tu, MD PhD, Dongmei Ji, MD PhD, Weina Shen, MD, Mingyuan Sun, MD, Ye Hua, MD, Chen Yang, MD, Chen Yu, MD, Jian Wang, PhD, Guangxiu Dai, PhD, Weiguo Su, PhD

Blood (2018) 132 (Supplement 1): 5324.

https://doi.org/10.1182/blood-2018-99-111648

Published: 2018

Journal Articles

Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Junyuan Qi, PhD, Yuqin Song, MD PhD, Bo Jiang, PhD, Jianyong Li, PhD, Meifeng Tu, PhD, Lingyan Ping, MD PhD, Zengjun Li, PhD, Wei Xu, MD PhD, Huayuan Zhu, MD PhD, Jun Zhu, MD PhD, Hanying Bao, MD PhD, Zusheng Xu, PhD, Lugui Qiu, MD PhD

Blood (2018) 132 (Supplement 1): 5332.

https://doi.org/10.1182/blood-2018-99-110585

Published: 2018

Journal Articles

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Yalu Liu, Ning Ding, MD, Xiaogan Wang, MD, Lijuan Deng, MD, Lingyan Ping, Yunfei Shi, Wen Zheng, Ningjing Lin, Xiaopei Wang, Meifeng Tu, Yan Xie, Weiping Liu, Zhitao Ying, Chen Zhang, Zhengying Pan, Xi Wang, Yuqin Song, MD, Jun Zhu, BS

Blood (2017) 130 (Supplement 1): 1461.

https://doi.org/10.1182/blood.V130.Suppl_1.1461.1461

Published: 2017

Journal Articles

Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease

Li Yu, Meifeng Tu, Jorge Cortes, Zijun Y. Xu-Monette, Roberto N. Miranda, Jun Zhang, Robert Z. Orlowski, Sattva Neelapu, Prajwal C. Boddu, Mary A. Akosile, Thomas S. Uldrick, Robert Yarchoan, L. Jeffrey Medeiros, Yong Li, David C. Fajgenbaum, Ken H. Young

Blood (2017) 129 (12): 1658–1668.

https://doi.org/10.1182/blood-2016-11-748855

Published: 2017

Journal Articles

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Blood (2013) 121 (20): 4021–4031.

https://doi.org/10.1182/blood-2012-10-460063

Published: 2013

Includes: Supplemental data

Journal Articles

Anemia in Lymphoma: The Role of Cytokines

Zonghong Shao, MD, Ting Wang, MD, Meifeng Tu, PhD, Jun Zhu, MD, Wen Zheng, MD

Blood (2012) 120 (21): 5103.

https://doi.org/10.1182/blood.V120.21.5103.5103

Published: 2012

Journal Articles

Study on Dendritic Cells in Peripheral Blood of the Patients with Autoimmune Hemolytic Anemia/Evans Syndromes.

Zonghong Shao, Limin Xing, Huaquan Wang, Meifeng Tu, Rong Fu

Blood (2007) 110 (11): 3874.

https://doi.org/10.1182/blood.V110.11.3874.3874

Published: 2007

Journal Articles

Quantitative Changes of T Helper Cell 3 and CD4 + CD25 + T Regulator Cells in Peripheral Blood and the Serum Levels of TGF-β1 of the Patients with Severe Aplastic Anemia.

Zonghong Shao, MD, Meifeng Tu, Hong Liu, Guangsheng He, Jun Shi, Jie Bai, Yanran Cao, Huaquan Wang, Limin Xing, Zhenzhu Cui, Juan Sun, Hairong Jia, Huisu Chen, Yanping Xue, Chongli Yang

Blood (2006) 108 (11): 3752.

https://doi.org/10.1182/blood.V108.11.3752.3752

Published: 2006

Journal Articles

Study on the Subtypes of Dendritic Cells and the Expression of T Cell Co-Stimulating Molecules (CD80, CD86, CD40) on Dendritic Cells and B Cells in the Peripheral Blood of SAA Patients.

Zonghong Shao, MD, Meifeng Tu, Hong Liu, Guangsheng He, Jun Shi, Jie Bai, Yanran Cao, Huaquan Wang, Limin Xin, Zhenzhu Cui, Juan Sun, Hairong Jia, Huisu Chen, Yanping Xue, Chongli Yang

Blood (2006) 108 (11): 3753.

https://doi.org/10.1182/blood.V108.11.3753.3753

Published: 2006

Journal Articles

CD5 + B Lymphocytes in the Bone Marrow of Immunic Hemocytopenia Patients and Its Clinical Significancy.

Zonghong Shao, Limin Xing, Rong Fu, Hong Liu, Jun Shi, Jie Bai, Meifeng Tu, Huaquan Wang, Zhenzhu Cui, Hairong Jia, Juan Sun, Chongli Yang

Blood (2005) 106 (11): 3905.

https://doi.org/10.1182/blood.V106.11.3905.3905

Published: 2005

Journal Articles

Aberrant Cell Cycle and Expression Profiles of Cell Cycle Regulatory Genes in Myelodysplastic Syndrome.

Zonghong Shao, Jun Shi, Hong Liu, Juan Sun, Hairong Jia, Jie Bai, Guangsheng He, Yanran Cao, Meifeng Tu, Huaquan Wang, Liming Xing

Blood (2005) 106 (11): 4897.

https://doi.org/10.1182/blood.V106.11.4897.4897

Published: 2005

Journal Articles

Study on the Burden of Abnormal Hematopoietic Clone of the Patients with Myelodysplastic Syndromes.

Zonghong Shao, Huaquan Wang, Jun Shi, Yanran Cao, Hong Liu, Jie Bai, Meifeng Tu, Liming Xing, Shihe Liu, Juan Sun, Hairong Jia

Blood (2005) 106 (11): 4899.

https://doi.org/10.1182/blood.V106.11.4899.4899

Published: 2005

NARROW

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Preliminary Results from a Phase 1 Study of HMPL-523, a Highly Selective Syk Inhibitor, in Chinese Patients with Mature B-Cell Lymphomas

Preliminary Results from a Phase I, First-in-Human Study of YY-20394, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

The Intracellular TCR Signaling Pathway As a Novel Therapeutic Target in AITL Patients

Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Anemia in Lymphoma: The Role of Cytokines

Study on Dendritic Cells in Peripheral Blood of the Patients with Autoimmune Hemolytic Anemia/Evans Syndromes.

Quantitative Changes of T Helper Cell 3 and CD4 + CD25 + T Regulator Cells in Peripheral Blood and the Serum Levels of TGF-β1 of the Patients with Severe Aplastic Anemia.

Study on the Subtypes of Dendritic Cells and the Expression of T Cell Co-Stimulating Molecules (CD80, CD86, CD40) on Dendritic Cells and B Cells in the Peripheral Blood of SAA Patients.

CD5 + B Lymphocytes in the Bone Marrow of Immunic Hemocytopenia Patients and Its Clinical Significancy.

Aberrant Cell Cycle and Expression Profiles of Cell Cycle Regulatory Genes in Myelodysplastic Syndrome.

Study on the Burden of Abnormal Hematopoietic Clone of the Patients with Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only